Nvidia is expanding its open AI model ecosystem to support healthcare and life sciences use cases, including drug discovery and biomedical research.
The effort includes continued development of the company’s BioNeMo and Clara model families, which support applications such as biological research, molecular modeling and medical imaging, according to a March 16 news release.
BioNeMo provides pretrained models and tools that help researchers analyze biological data, model proteins and design potential drug compounds, with the goal of accelerating pharmaceutical discovery and development.
Clara includes AI tools and models for healthcare applications such as medical imaging, digital pathology and genomics, enabling organizations to build and deploy AI-driven clinical and research workflows.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
